Search Results - "Bhamidipati, Ravi Kanth"

Refine Results
  1. 1
  2. 2
  3. 3

    Validated LC–MS-MS Method for Determination of SF0034 in Mice Plasma: Application to a Pharmacokinetic Study in Mice by Todmal, Umesh, Suresh, P. S., Zainuddin, Mohd, Kanth Bhamidipati, Ravi, Samanta, Swapan Kumar, Hallur, Gurulingappa, Rajagopal, Sridharan, Rajagopal, Sriram, Mullangi, Ramesh

    Published in Journal of chromatographic science (01-08-2017)
    “…Abstract A rapid and sensitive assay method has been developed and validated using liquid chromatography coupled to tandem mass spectrometry with electrospray…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models by Bhamidipati, Ravi Kanth, Syed, Muzeeb, Mullangi, Ramesh, Srinivas, Nuggehally

    Published in Xenobiotica (01-02-2018)
    “…1. Dalbavancin, a lipoglycopeptide, is approved for treating gram-positive bacterial infections. Area under plasma concentration versus time curve (AUC inf )…”
    Get full text
    Journal Article
  6. 6

    LC–MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice by Saini, Neeraj Kumar, Suresh, P.S., Lella, Mahalakhsmi, Bhamidipati, Ravi Kanth, Rajagopal, Sriram, Mullangi, Ramesh

    “…[Display omitted] •First bioanalytical method being reported for quantification of tideglusib in mice plasma on LC–MS/MS.•Simple sample processing method and…”
    Get full text
    Journal Article
  7. 7

    Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor by Balakrishna, Vinod Anera, Police, Anitha, Hiremath, Rakesh, Raj, Anusha, Sulochana, Suresh P, Chandrasekhar, Devaraj V, Mohd, Zainuddin, Bhamidipati, Ravi Kanth, Mullangi, Ramesh

    Published in ADMET & DMPK (01-12-2017)
    “…Ulixertinib (BVD-523) is a novel and selective reversible inhibitor of ERK1/ERK2. In xenograft studies it inhibited tumor growth in BRAF-mutant melanoma and…”
    Get full text
    Journal Article Paper
  8. 8
  9. 9

    Interspecies scaling of urinary excretory amounts of nine drugs belonging to different therapeutic areas with diverse chemical structures - accurate prediction of the human urinary excretory amounts by Bhamidipati, Ravi Kanth, Mullangi, Ramesh, Srinivas, Nuggehally R.

    Published in Xenobiotica (01-02-2017)
    “…1. The human urinary excretory amounts of total drug (parent + metabolites) were predicted for nine drugs with diverse chemical structures using simple…”
    Get full text
    Journal Article
  10. 10

    Cover Image by Dittakavi, Sreekanth, Mahadevan, Lavanya, Chandrashekar, Devaraj V., Bhamidipati, Ravi Kanth, Suresh, Juluri, Dhakshinamoorthy, Saravanakumar, Li, Ziyu, Baerenz, Felix, Tennagels, Norbert, Mullangi, Ramesh

    Published in Biomedical chromatography (01-05-2020)
    “…The cover image is based on the Short Communication High throughput screening assay for quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study by Police, Anitha, Gurav, Sandip, Dhiman, Vinay, Zainuddin, Mohd, Bhamidipati, Ravi kanth, Rajagopal, Sriram, Mullangi, Ramesh

    Published in Biomedical chromatography (01-11-2015)
    “…A simple, specific, sensitive and reproducible high‐performance liquid chromatography (HPLC) assay method has been developed and validated for the estimation…”
    Get full text
    Journal Article
  16. 16

    Prediction of Human Pharmacokinetics of Bendamustine from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles by Jairam, Ravi Kumar, Mallurwar, Sadanand Rangnathrao, Sulochana, Suresh P, Chandrasekar, Devaraj V, Bhamidipati, Ravi Kanth, Richter, Wolfgang, Srinivas, Nuggehally R, Mullangi, Ramesh

    Published in Drug research (01-01-2019)
    “…Bendamustine, an alkylating anticancer agent, is used to treat chronic lymphocytic leukemia by intravenous infusion alone or in combination. The work aimed to…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    LC‐ESI‐MS/MS determination of 4‐methylpyrazole in dog plasma and its application to a pharmacokinetic study in dogs by Chandrasekhar, Devaraj V., Suresh, Ponnayyan Sulochana, Dittakavi, Sreekanth, Hiremath, Rakesh A., Bhamidipati, Ravi Kanth, Richter, Wolfgang, Srinivas, Nuggehally R., Mullangi, Ramesh

    Published in Biomedical chromatography (01-02-2018)
    “…A simple, specific, sensitive and rapid LC‐ESI‐MS/MS method has been developed and validated for the quantification of 4‐methylpyrazole in dog plasma using…”
    Get full text
    Journal Article
  20. 20